The treatment works by helping your body balance insulin and glucagon, two hormones that are important for maintaining blood sugar levels
Wegovy injection showed weight loss of 15% in its key trial, versus 2% for placebo, while Zepbound showed 21% on its highest dose, compared with 3% for those on placebo
These mechanisms lead to improved glycaemic control and, commonly, significant weight loss
These results must be documented and reviewed
Medicare: Contrary to the old Medicare doesnt cover weight loss drugs rule of thumb, a Medicare GLP-1 Bridge pilot begins July 1, 2026 with a $50 monthly copay for eligible enrollees
Weight loss medication, the right way, with Reviv GLP-1s and personalized weight loss meds delivered to your door Lose 48% more with Reviv Lounge than weight loss medication alone No long-term commitment or hidden fees Custom-Tailored GLP-1 Weight Loss with Semaglutide & Tirzepatide Lose weight with science-backed medication, personalized support, and unmatched care